Bionano Genomics raises ~$3M in registered direct offering of 9.9M shares and warrants at $0.3039/unit

Bionano Genomics, Inc.

Issued 9,881,113 shares of common stock and Series C/D warrants to purchase up to 9,881,113 shares each at $0.3039 per share.
Gross proceeds of $3M from offering, with potential additional $6M if warrants fully exercised on cash basis.
Closing expected on October 31, 2024; H.C. Wainwright acted as exclusive placement agent with 6% cash fee.
Net proceeds to be used for working capital, R&D, repayment or redemption of existing indebtedness, and capex.
Warrants exercisable only after stockholder approval; Series C expires in 5 years, Series D in 18 months.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.